Increase of imipenem resistance among Pseudomonas aeruginosa isolates from a Polish paediatric hospital (1993-2002)

International Journal of Antimicrobial Agents

Volumn 29, Issue 2, 2007, Pages 153-158

  Patzer, Jan A ^a   Dzierzanowska, Danuta ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Imipenem; MIC; PFGE; Pseudomonas aeruginosa; Serotypes; Susceptibility

Indexed keywords

AMIKACIN; AZTREONAM; CARBENICILLIN; CEFOPERAZONE; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG SENSITIVITY; INTENSIVE CARE UNIT; MOLECULAR CLONING; NONHUMAN; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE;

ANTI-BACTERIAL AGENTS; CHILD; DRUG RESISTANCE, BACTERIAL; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; TIME FACTORS;

EID: 33846037873     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.08.044     Document Type: Article

References (20)

1. Morrison Jr. A.J., and Wenzel R.P. Epidemiology of infections due to Pseudomonas aeruginosa. Rev Infect Dis 6 (1984) S627-S642
2. Cross A.S. Evolving epidemiology of Pseudomonas aeruginosa infections. Eur J Clin Microbiol 4 (1985) 156-159
3. Gales A.C., Jones R.N., Turnidge J., Rennie R., and Ramphal R. Characterization of Pseudomonas aeruginosa isolates: susceptibility patterns, and molecular typing in the global SENTRY antimicrobial surveillance program, 1997-1999. Clin Infect Dis 32 Suppl. 2 (2001) S146-S155
4. Quinn J.P., Studemeister A.E., DiVincenzo C.A., and Lerner S.A. Resistance to imipenem in Pseudomonas aeruginosa; clinical experience and biochemical mechanisms. Rev Infect Dis 10 (1988) 892-898
5. Livermore D.M. Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 36 (1992) 2046-2048
6. Poole K., Krebes K., McNally C., and Neshat S. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol 175 (1993) 7363-7372
7. Ziha-Zarifi I., Llanes C., Kohler T., Pechere J.C., and Plesiat P. In vivo emergence of multidrug- resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM. Antimicrob Agents Chemother 43 (1999) 287-291
8. Livermore D.M. Of Pseudomonas, porins, pumps and carbapenems. J Antimicrob Chemother 47 (2001) 247-250
9. Livermore D.M., and Woodford N. Carbapenemases: a problem is waiting?. Curr Opin Microbiol 3 (2000) 489-495
10. Nordmann P., and Poirel L. Emerging carbapenemases in gram-negative aerobes. Clin Microbiol Infect 8 (2002) 321-331
11. Brokopp C.D., Gómez-Lus R., and Farmer J.J. Serological typing of Pseudomonas aeruginosa: use of commercial antisera and live antigens. J Clin Microbiol 11 (1977) 640-649
12. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial test for bacteria that grow aerobically. Document M-7-A6. Wayne, PA: NCCLS; 2003.
13. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Document M100-S13, Wayne, PA: NCCLS; 2003.
14. Tenover F.C., Arbeit R.D., Goering R.V., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33 (1995) 2233-2239
15. Troillet N., Samore M.H., and Carmeli Y. Imipenem-resistant Pseudomonas aeruginosa risk factors and antibiotic susceptibility patterns. Clin Infect Dis 25 (1997) 1094-1098
16. Carmell Y., Troillet N., Eliopoulos G.M., and Samore M.H. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother 43 (1999) 1379-1382
17. Lepper P.M., Grusa E., Reichl H., Ho{combining double acute accent}gel J., and Trautmann M. Consumption of imipenem correlates with β-lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 46 (2002) 2920-2925
18. Patzer J., Dzierżanowska D., and Turner P. Susceptibility patterns of Gram-negative bacteria from a Polish intensive care unit, 1997-2000. Int J Antimicrob Agents 19 (2002) 431-434
19. Giamarellou H. Prescribing guidelines for severe Pseudomonas infections. J Antimicrob Chemother 49 (2002) 229-233
20. Patzer J., Toleman M.A., Deshpande L.M., et al. Pseudomonas aeruginosa strains harbouring an unusual blaVIM-4 gene cassette isolated from hospitalized children in Poland (1998-2001). J Antimicrob Chemother 53 (2004) 451-456